MimeKit 5.0 is a major release containing a number of breaking changes. The headline changes are the split of the cryptography support into its own assembly, the promotion of the new MIME parser, a ...
Stack Overflow is privately owned by Prosus and is not publicly traded. Invest in Prosus to gain indirect exposure to Stack Overflow’s growth and AI integration. Prosus also offers exposure through ...
Recursive Flint is a 40B MoE local coding model with 2.5B active parameters, scoring 74.2% on SWE-bench Verified.
Salt Lake City, UT, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Anthropic co-founder Dario Amodei urges a deliberate slowdown in AI development, emphasizing ...
Recursion Pharmaceuticals leverages an artificial intelligence platform to decode biology and automate the drug discovery process. Summit Therapeutics is focused on its lead oncology candidate, ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Stack Overflow launched a public beta of Stack Overflow for Agents on June 10, opening a new API-first knowledge platform where AI coding agents can retrieve validated debugging knowledge before ...
Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...
Recursion Pharmaceuticals, Inc. remains a Hold as competitive risks persist and the company is years away from meaningful pipeline revenue. RXRX's AI-driven Recursion OS platform shows strong ...
Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results